07:00 , May 26, 2014 |  BC Week In Review  |  Financial News

Sorbent completes venture financing

Sorbent Therapeutics Inc., Sunnyvale, Calif.   Business: Renal, Cardiovascular   Date completed: 5/15/14   Type: Venture financing   Raised: $6.5 million   Investors: CMEA Capital; Arch Venture Partners; Sofinnova Ventures; AgeChem Venture Fund; Novartis Venture Funds   Note: Sorbent raised $6.5...
07:00 , Jun 10, 2013 |  BC Week In Review  |  Financial News

Akebia completes venture financing

Akebia Therapeutics Inc., Cincinnati, Ohio   Business: Hematology, Cardiovascular   Date completed: 6/4/13   Type: Venture financing   Raised: $41 million   Investors: Satter Investment Management; Novo A/S; Novartis Venture Funds; Kearny Venture Partners; Venture Investors LLC; Athenian Venture Partners;...
01:00 , Jun 5, 2013 |  BC Extra  |  Top Story

Akebia raises $41 million series C

Anemia company Akebia Therapeutics Inc. (Cincinnati, Ohio) raised $41 million in a series C round co-led by new investors Satter Investment Management and Novo A/S. Existing investors Novartis Venture Fund; Kearny Venture Partners; Venture Investors;...
08:00 , Nov 12, 2012 |  BC Week In Review  |  Financial News

Alethia completes venture financing

Alethia BioTherapeutics Inc., Montreal, Quebec   Business: Cancer, Genomics   Date completed: 11/1/12   Type: Venture financing   Raised: C$4.7 million ($4.7 million)   Investors: AgeChem Venture Fund; BDC Venture Capital; GO Capital Fund; Cellscript of Wisconsin   Note: The financing...
07:00 , Sep 3, 2012 |  BC Week In Review  |  Financial News

Aerpio Therapeutics completes venture financing

Aerpio Therapeutics Inc., Cincinnati, Ohio   Business: Ophthalmic, Autoimmune, Dermatology   Date completed: 8/30/12   Type: Venture financing   Raised: $27 million   Investors: Novartis BioVenture Fund; Venture Investors LLC; Triathlon Medical Ventures; Kearney Venture Partners; Athenian Venture Partners; AgeChem...
00:19 , Aug 31, 2012 |  BC Extra  |  Financial News

Aerpio raises $27M in series A

Aerpio Therapeutics Inc. (Cincinnati, Ohio) raised $27 million in a series A round led by Novartis BioVentures. Venture Investors; Triathlon Medical Ventures; Kearny Venture Partners; Athenian Venture Partners; and AgeChem Venture Fund also participated. Aerpio...
08:00 , Jan 16, 2012 |  BC Week In Review  |  Financial News

Akebia financial update

Akebia raised $4.1 million in a second tranche of a series B round, bringing the total raised in the round to $18.1 million. Existing investors Novartis Venture Funds; Venture Investors; Triathlon Medical Ventures; Kearny Venture...
08:00 , Jan 9, 2012 |  BioCentury  |  Finance

Project management

Project management Akebia Therapeutics Inc. has decided the best way to manage its diverse clinical-stage assets is to spin out a newco - Aerpio Therapeutics Inc.Akebia will focus on anemia, while Aerpio will focus on diabetic...
07:00 , Jul 4, 2011 |  BC Week In Review  |  Financial News

Sorbent financial update

Sorbent raised $36 million in a second tranche of a series B round, bringing the total raised in the round to $53 million. New investor Novartis Venture Funds led the tranche, with existing investors Sofinnova...
01:21 , Jul 1, 2011 |  BC Extra  |  Financial News

Sorbent raises $36M in expanded B round

Sorbent Therapeutics Inc. (Sunnyvale, Calif.) raised $36 million in a second tranche of a series B round, bringing the total raised in the round to $53 million. New investor Novartis Venture Funds led the tranche,...